Lipoprotein(a) Cardiovascular Risk: Results, Ranges & Interpretation

Lipoprotein(a), often abbreviated as Lp(a), is a lipid particle similar to LDL cholesterol that is largely genetically determined. High levels of Lp(a) are an independent cardiovascular risk factor, meaning they increase heart disease and stroke risk even when other cholesterol levels are normal. Unlike other cholesterol types, Lp(a) levels are primarily determined by genetics rather than diet or lifestyle, making genetic testing and family history particularly important.

How to interpret your results

Your Lipoprotein(a) result is a single number, but the interpretation depends entirely on which unit your lab used. Labs report Lp(a) in two different units: milligrams per deciliter (mg/dL) and nanomoles per liter (nmol/L). The preferred reporting unit is nmol/L, but many labs still use mg/dL. Always compare your value against the reference range printed on your own report, and confirm with your provider which measurement they used.

Because Lp(a) is largely genetically determined, a one-time test usually suffices for screening. Levels typically reach their adult value by age 5 and stay roughly constant for life. That makes Lp(a) different from LDL cholesterol, which rises with age and responds to diet and exercise — you generally do not need to recheck Lp(a) every year.

Reference ranges by unit

Two threshold systems are commonly used. Cleveland Clinic publishes tiered cutoffs in mg/dL, while Harvard Health and several international consensus groups use simple normal-versus-high bands in both units.

Sources: Cleveland Clinic tiered bands; Harvard Health two-band cutoffs.

There is no universal consensus on the exact abnormal threshold, which is why the bands above differ slightly between guidelines. What is consistent across sources: the higher your Lp(a), the higher your inherited risk of heart attack, stroke, peripheral artery disease, heart failure, coronary artery disease, and aortic valve stenosis.

What an elevated result actually predicts

High Lp(a) can double or even triple a person’s risk of heart attack and is considered a common driver of heart disease that strikes at a young age. The mechanism is multi-pronged. Lp(a) particles are stickier than ordinary LDL and are more likely to build plaque inside arteries. They also promote blood clot formation, and once a clot forms it is harder for the body to break it down.

An important caveat: a high Lp(a) can elevate cardiovascular risk even when your standard cholesterol panel looks normal. A routine lipid panel measures total LDL but does not separate out the Lp(a) fraction — so a reassuring LDL number does not rule out elevated inherited risk.

How to prepare for the Lp(a) blood test

The Lp(a) test itself is a routine blood draw from a vein in your arm, typically completed in less than five minutes. Preparation is straightforward but has a few specifics worth getting right, because several common substances can influence the result.

Fasting. Preparation requirements depend on the lab running the test, but most labs ask you to fast — no food or drink other than water — for 9 to 12 hours before the blood draw. Confirm with your ordering clinician or the lab whether fasting applies to your specific order.

Substances and medications that can affect your result. Before your test, tell your provider if you have been using any of the following. Each has been shown to influence Lp(a) readings:

• Alcohol
• Niacin supplements
• Aspirin
• Oral estrogen hormones, including hormone therapy taken by mouth

Cleveland Clinic also flags menopause itself as a state that can shift Lp(a) results. If you are perimenopausal, postmenopausal, or on hormone therapy, mention it when your test is ordered so the result can be interpreted in context.

Risks. The risks of the blood draw itself are minor — slight pain or bruising at the puncture site that usually resolves quickly. Because Lp(a) is genetically stable, you generally will not need to repeat the test annually the way you do with a standard lipid panel.

Who should get tested for Lp(a) (and why screening is rare)

Lp(a) is not part of a standard lipid panel — a clinician has to specifically request it. Historically, very few people received the test. Recent data show that only 0.3% of people had Lp(a) screening between 2012 and 2019 in the United States. About half of those tests were ordered by a small number of providers.

That under-screening is changing. International consensus groups now recommend one-time Lp(a) testing for every adult, and routine testing is already standard in Europe. In the United States, the first official endorsement of Lp(a) testing came in 2024 from the National Lipid Association, and most U.S. insurers in most states now cover the test.

Groups specifically recommended for testing

Even in the absence of universal screening, several groups should be tested. MedlinePlus, Cleveland Clinic, and Harvard Health agree on the core indications, summarized below.

• Family history of premature cardiovascular disease. A father or brother with heart or blood vessel disease before age 55, or a mother or sister before age 65.
• Personal history of premature CVD. A heart attack, stroke, peripheral artery disease, or aortic stenosis before age 55 in men or 65 in women.
• Very high LDL cholesterol. LDL of 190 mg/dL or higher, with or without medication.
• Heart or vessel disease despite normal cholesterol. If you have cardiovascular disease but your routine cholesterol and triglyceride numbers are normal without lipid medication.
• Signs of familial hypercholesterolemia (FH). An inherited high-cholesterol condition — more than 30% of people with FH also have high Lp(a).
• Recurrent cardiac events. More than one heart attack, more than one angioplasty, or repeated heart events despite risk-factor management.
• Close relatives of someone with known elevated Lp(a). Siblings, children, and parents — this is “cascade” family screening.

The pattern across these indications is the same: Lp(a) testing is targeted at people whose family or clinical history hints that an inherited driver may be at work, especially when a routine cholesterol workup looks deceptively reassuring.

Lp(a) vs LDL and other cholesterol markers

Lp(a) sits inside the broader cholesterol picture but is measured and interpreted differently from the markers on a routine lipid profile. Understanding where it fits clarifies why a “normal” cholesterol panel does not always mean low cardiovascular risk.

Lp(a) vs LDL cholesterol

Lp(a) is technically a type of LDL — a low-density lipoprotein particle that carries cholesterol through the bloodstream — but it has an extra protein attached, called apolipoprotein(a), that makes it behave differently from ordinary LDL. Several practical differences matter for interpretation:

Sources: panel inclusion and special-request requirement; diet and exercise have virtually no effect on Lp(a); adult level reached by age 5 and stable for life; statins do not lower Lp(a) meaningfully, though they may still be used to manage overall cardiovascular risk.

The clinical consequence is straightforward: a routine cholesterol test may report a “healthy” LDL number, but if a large share of that LDL is actually being carried by Lp(a) particles, your cardiovascular risk can still be high.

Lp(a) vs apolipoprotein B and other markers

Lp(a) is distinct from other inherited or particle-based risk markers like the ApoA1/ApoB ratio and from inflammatory markers like hs-CRP. Each measures a different aspect of cardiovascular risk — particle structure, particle number, or vascular inflammation — and they are not interchangeable. Lp(a) specifically captures an inherited, lipid-particle-based risk that ordinary cholesterol numbers can miss, which is why it is recommended for targeted use rather than universal annual screening.

Frequently asked questions

What does the Lp(a) test actually measure?

The test measures the concentration of lipoprotein(a) particles in your blood, reported in either mg/dL or nmol/L. The result reflects an inherited, lifelong risk factor that a standard cholesterol panel does not capture, even when your overall LDL looks healthy.

Can I lower my Lp(a) with diet or exercise?

Lifestyle changes have virtually no direct effect on Lp(a) itself, because Lp(a) levels are set by your genes and reach their adult value by age 5. Heart-healthy habits still matter, though — they reduce your overall cardiovascular risk, which is the practical goal when Lp(a) cannot be moved.

Are there foods to avoid if my Lp(a) is high?

No specific food or food group has been shown to drive Lp(a) up or down — diet has minimal direct effect on the value. The same heart-healthy eating pattern recommended for general cardiovascular prevention applies: focus on overall LDL, blood pressure, and weight management rather than chasing an “Lp(a) diet”.

What are the symptoms of high Lp(a)?

Most people with elevated Lp(a) have no symptoms at all — it is a silent risk factor, and blood testing is the only way to detect it. That is why family history is so important: if a close relative is known to have high Lp(a), it is worth asking your clinician whether you should be tested too.

Do I need to fast before the Lp(a) test?

Fasting requirements depend on the lab, but most labs ask you to fast for 9 to 12 hours — no food or drink other than water — before the blood draw. Your ordering clinician will confirm the specific instructions for your test.

Do Lp(a) levels change over time?

Lp(a) is largely stable across your lifetime — your adult level is typically reached by age 5 and stays roughly the same afterward. That is why a one-time test usually suffices for screening, unlike LDL cholesterol, which is rechecked periodically. Researchers are still studying changes that may occur around menopause.

Is there a drug that lowers Lp(a)?

No medication is currently approved by the U.S. Food and Drug Administration specifically to lower Lp(a). Several RNA-based drugs — lepodisiran, olpasiran, pelacarsen, and zerlasiran — and an oral assembly inhibitor called muvalapin are in clinical trials. They have shown 80%–100% reductions in Lp(a). Larger outcome trials are expected to read out within the next one to two years.

When to talk to your doctor

Lp(a) is not a routine annual test. The right time to bring it up with a clinician is when something in your personal or family history suggests an inherited cardiovascular risk that a standard cholesterol panel may miss. Specific scenarios worth raising:

• You have a father or brother who had heart or blood vessel disease before age 55, or a mother or sister who had it before age 65.
• You have had a heart attack, stroke, peripheral artery disease, or aortic stenosis before age 55 (men) or 65 (women).
• Your LDL cholesterol is 190 mg/dL or higher, with or without medication.
• You have had more than one heart attack, more than one angioplasty, or repeated heart events despite managing your known risk factors.
• You have heart or blood vessel disease but your routine cholesterol and triglyceride numbers are normal without medication.
• You or a relative has been told you have familial hypercholesterolemia, since more than 30% of people with FH also have elevated Lp(a).
• A close family member (sibling, child, or parent) has a confirmed elevated Lp(a) level — cascade testing of first-degree relatives is specifically recommended.
• You are entering or going through menopause and are reviewing your cardiovascular risk profile, since hormonal change can affect Lp(a) interpretation.
• You currently take oral estrogen hormones, niacin supplements, or aspirin, all of which can influence Lp(a) results and should be disclosed before testing.

If your Lp(a) comes back elevated, the conversation typically shifts toward managing every modifiable cardiovascular risk factor more aggressively — LDL cholesterol, blood pressure, blood glucose, smoking, weight — rather than trying to lower the Lp(a) value itself, because no approved Lp(a)-lowering drug is yet on the market. In rare cases involving familial hypercholesterolemia with very high Lp(a), specialty options like lipoprotein apheresis may be considered, but only under cardiology and lipidology supervision.

References

• MedlinePlus (U.S. National Library of Medicine, NIH)
• Cleveland Clinic
• Harvard Health Publishing

Last reviewed: 2026-05-17